Explore more publications!

Press Releases

BlueGrace Energy Bolivia Unveils 2025 Milestones in Renewable Energy, ESG Technology, and Tokenized Climate Finance
Invest in Bogotá and Banco de Occidente Promote New Infrastructure Investment Opportunities from Cartagena
[CAGR of 5%] Beta-Alanine Market Size, Share, Growth & Research Report, 2033
Aura Minerals Closes the Acquisition of the Mineração Serra Grande Gold Mine in Goias, Brazil (“MSG”)
Influential Women Profiles Veronica Vejar: Lead Product Designer and UX Researcher
Transpovia Expands Airport Transfer Network Across the Americas With New Automation Technology
Nanoclays Market Growth, Emerging Technologies, Opportunity and Forecast to 2031 | AMR
Colombian leader denounces Trump’s remarks on destroying drug labs

Colombian leader denounces Trump’s remarks on destroying drug labs

Integral Systems S.A.S and FasterCapital Launch Partnership to Transform Colombia’s Tech Landscape
We Were Here Venice Biennale Film on Blacks in Renaissance Europe Enters Oscar Consideration for 2026
Petro criticizes Trump over threat to target Colombian drug factories

Petro criticizes Trump over threat to target Colombian drug factories

Petro Addresses Trump’s Comments on Colombian Cocaine Factories

Petro Addresses Trump’s Comments on Colombian Cocaine Factories

Karbon-X Advances Community-Led Forest Protection in Colombia’s Meta Region
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
Colombia Suspends Intelligence Ties with U.S. After Caribbean Strikes

Colombia Suspends Intelligence Ties with U.S. After Caribbean Strikes

Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse
Clinical Laboratory Instruments Market to Reach US$ 91.61 Billion by 2033 at 7.4% CAGR | DataM Intelligence
Engineered Wood Market to Reach $427.3 billion by 2033 at 5.3% CAGR: Allied Market Research
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions